02185.HK
Shanghai Bio-heart Biological Technology Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 1.82
−0.55%Margins
Gross margin
15.0%
EBITDA margin
-188.1%
EBIT margin
-238.5%
Net margin
-278.8%
FCF margin
-124.2%
-40.7%
Return on equity
-20.7%
Return on assets
-33.9%
Return on invested capital
0.07x
Asset turnover
-HKD 76.3M
Cash from operations
HKD 1.14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026